| Nov 14 |
Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference
|
| Nov 12 |
Beyond Air, Inc. (XAIR) Q2 2025 Earnings Call Transcript
|
| Nov 11 |
Beyond Air GAAP EPS of -$0.28 in-line, revenue of $0.79M misses by $0.24M
|
| Nov 11 |
Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update
|
| Nov 11 |
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
|
| Nov 11 |
Earnings Scheduled For November 11, 2024
|
| Nov 8 |
A Peek at Beyond Air's Future Earnings
|
| Oct 29 |
Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast
|
| Oct 25 |
Beyond Air files to sell 81.7M shares of common stock for holders
|
| Oct 7 |
Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
|
